UroGen Pharma(URGN) - 2020 Q4 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2020 Results Earnings Conference Call March 18, 2021 8:30 AM ET Company Participants Sara Sherman - Head, Investor Relations Liz Barrett - President and CEO Dr. Mark Schoenberg - Chief Medical Officer Jeff Bova - Chief Commercial Officer Molly Henderson - Chief Financial Officer Conference Call Participants Chris Howerton - Jefferies Derek Archila - Stifel Hannah Adeoye - J.P. Morgan Matt Kaplan - Ladenburg Thalmann Paul Choi - Goldman Sachs Operator Good morning, ladies ...